New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 10, 2014
08:17 EDTNWBONorthwest Biotherapeutics initiates Phase III trial of DCVax-L in Germany
Northwest Biotherapeutics announced that it has initiated the Phase III trial of DCVax-L in Germany. The first site to open in Germany was a medical center in Dresden, which was initiated in late May. The Company has now scheduled the full-day site initiations for 3 more sites during June and 4 further sites in July.
News For NWBO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 16, 2015
17:28 EDTNWBONorthwest Biotherapeutics files to delay Form 10-K
The company requires additional time to complete its year end procedures. Those procedures could not be completed without incurring undue hardship and expense. The company undertakes the responsibility to file such annual report no later than fifteen days after its original date.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use